Related Experiment Video
Updated: May 27, 2025

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
Published on: August 23, 2022
Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2-4 Weeks of Life: Clinical
Sanjiv Harpavat1, Susan W Aucott2, Saul J Karpen3
1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
Insights
This strategy helps identify infants with biliary atresia early. It uses simple checks at the one-month well-child visit to guide bilirubin testing, potentially reducing liver transplants.
Area of Science:
- Pediatric Medicine
- Neonatal Health
- Gastroenterology
Background:
- Biliary atresia is a serious condition in infants.
- Early identification is crucial for better outcomes.
- Current diagnostic methods can be delayed.
Purpose of the Study:
- To provide a simple strategy for primary care providers.
- To facilitate early detection of biliary atresia in infants.
- To reduce the need for liver transplantation through timely intervention.
Main Methods:
- Utilizes the "By 1 month" well-child visit (2-4 weeks of life).
- Involves assessment of infant eye color and stool color.
- Considers prior laboratory results to guide further testing.
Main Results:
- Aims to quickly identify infants needing direct or conjugated bilirubin level measurement.
- Potential to streamline the diagnostic pathway for biliary atresia.
- Facilitates earlier referral and treatment initiation.
Conclusions:
- This strategy offers a practical approach for early biliary atresia detection.
- Improved identification can lead to better patient outcomes.
- Early intervention may decrease the incidence of liver transplantation in affected infants.
Abstract:
This report helps pediatric primary care providers quickly identify infants with biliary atresia, which has the potential to improve outcomes and reduce need for liver transplant. The strategy is intended to be used between 2 and 4 weeks of life at the "By 1 month" well-child visit in the Bright Futures/American Academy of Pediatrics "Recommendations for Preventive Pediatric Health Care." The strategy involves examining every infant's eye color, stool color, and prior laboratory results to determine whether measurement of a direct or conjugated bilirubin level is warranted.
Related Concept Videos
Endoscopic Procedures V: ERCP
Patient...
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...

